A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 133 participants.
Also called NCT04671771
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 133 participants
- Sponsor
- Registry
-
NCT04671771
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04671771. Allocation not applicable; no masking; primary purpose treatment. Start 2020-12-03 (actual); primary completion 2030-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Condition
- End Stage Renal Disease (ESRD)
- Condition
- Kidney Failure
- Condition
- Chronic Renal Disease
- Condition
- Hemodialysis
- Intervention (Device)
- InnAVasc Arteriovenous Graft (IG) surgical implant
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct04671771- Content hash
8487ed2866c72b0cd4cac91f0263f08965f9ba98a8c6b605bf8223a585bec035